Mitochondria‐targeted atovaquone promotes anti‐lung cancer immunity by reshaping tumor microenvironment and enhancing energy metabolism of anti‐tumor immune cells

Authors:

Abstract
No abstract available
Funding Information
  • National Institutes of Health (R01CA223804)
  • National Institutes of Health (R01CA232433)
  • National Institutes of Health (R01CA205633)
  • National Institutes of Health (R01CA280746)

This publication has 10 references indexed in Scilit: